micafungin and Failure-to-Thrive

micafungin has been researched along with Failure-to-Thrive* in 1 studies

Other Studies

1 other study(ies) available for micafungin and Failure-to-Thrive

Article	Year
Antifungal lock therapy with combined 70% ethanol and micafungin in a critically ill infant. The Pediatric infectious disease journal, 2014, Volume: 33, Issue:4 So-called lock therapy, consisting of high concentrations of antimicrobials instilled into the lumen of the catheter, has been suggested avoid central venous catheter removal during fungal infection. We report a baby who developed catheter-related candidemia. Systemic antifungal treatment did not resolve the candidemia. Lock therapy with 0.3 mL of ethanol 70% and micafungin sodium 5 mg/L was added to the therapy, and blood cultures became sterile. Topics: Antifungal Agents; Candida albicans; Candidemia; Catheter-Related Infections; Central Venous Catheters; Critical Illness; Echinocandins; Ethanol; Failure to Thrive; Humans; Infant; Lipopeptides; Male; Micafungin; Parenteral Nutrition	2014

Article

Year

Antifungal lock therapy with combined 70% ethanol and micafungin in a critically ill infant.

The Pediatric infectious disease journal, 2014, Volume: 33, Issue:4

So-called lock therapy, consisting of high concentrations of antimicrobials instilled into the lumen of the catheter, has been suggested avoid central venous catheter removal during fungal infection. We report a baby who developed catheter-related candidemia. Systemic antifungal treatment did not resolve the candidemia. Lock therapy with 0.3 mL of ethanol 70% and micafungin sodium 5 mg/L was added to the therapy, and blood cultures became sterile.

Topics: Antifungal Agents; Candida albicans; Candidemia; Catheter-Related Infections; Central Venous Catheters; Critical Illness; Echinocandins; Ethanol; Failure to Thrive; Humans; Infant; Lipopeptides; Male; Micafungin; Parenteral Nutrition

2014